Evidence map›Paper›PMID 34142364›Full record

ArticleJournal of endocrinological investigation2022

The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study.

I Barchetta, S Dule, L Bertoccini, F A Cimini, F Sentinelli, D Bailetti, G Marini, A Barbonetti, S Loche, E Cossu and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of endocrinological investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

I BarchettaDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
S DuleDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
L BertocciniDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
F A CiminiDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
F SentinelliDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
D BailettiDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, L'Aquila, Italy.
G MariniDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
A BarbonettiDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, L'Aquila, Italy.
S LochePediatric Endocrine Unit, Ospedale Pediatrico Microcitemico "A. Cao", Cagliari, Italy.
E CossuDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
M G CavalloDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
M G BaroniDepartment of Clinical Medicine, Public Health, Life and Environmental Sciences (MeSVA), University of L'Aquila, L'Aquila, Italy. marcogiorgio.baroni@univaq.it.ORCID http://orcid.org/0000-0002-3224-6078
Sapienza University of Rome · ITUniversity of L'Aquila · ITUniversity of Cagliari · ITOspedale Microcitemico · IT

Funding

MeSVA Dept., Unversity of L'Aquila Bando Ricerca FFO 2020 and FFO 2021Sapienza Università di Roma Ricerca Ateneo 2019
6 · The paper itself

Abstract

purposeTo investigate the relationship between the single-point insulin sensitivity estimator (SPISE) index, an insulin sensitivity indicator validated in adolescents and adults, and metabolic profile in overweight/obese children, and to evaluate whether basal SPISE is predictive of impaired glucose regulation (IGR) development later in life.

methodsThe SPISE index (= 600 × HDL

resultsAt baseline, 96/909 (11%) overweight/obese children had IGR; in this subgroup, SPISE was significantly lower than in normo-glycaemic youths (6.3 ± 1.7 vs. 7 ± 1.6, p < 0.001). The SPISE index correlated positively with the insulin sensitivity index (ISI) and the disposition index (DI), negatively with age, blood pressure, HOMA-IR, basal and 120 min blood glucose and insulin (all p values < 0.001). A correlation between SPISE, HOMA-IR and ISI was also reported in normal-weight children. At the 6.5-year follow-up, lower basal SPISE-but not ISI or HOMA-IR-was an independent predictor of IGR development (OR = 3.89(1.65-9.13), p = 0.002; AUROC: 0.82(0.72-0.92), p < 0.001).

conclusionIn children, low SPISE index is significantly associated with metabolic abnormalities and predicts the development of IGR in life.

Indexed as

Glucose Metabolism DisordersInsulin ResistanceMetabolomeOverweightPediatric ObesityAdolescentAdultAge FactorsBlood GlucoseBody Mass IndexFemaleHumansInsulin SecretionItalyMalePredictive Value of TestsBlood GlucoseTriglyceridesChildhood obesityImpaired glucose regulationInsulin resistanceInsulin-sensitivity indexScreeningSPISE

Identifiers

PMID34142364
PMCPMC8741725
OpenAlexW3170756460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.